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Abstract.  The structural elements required for normal 
maturation and assembly of the nicotinic acetylcholine 
receptor a  subunit were investigated by expression of 
mutated subunits in transfected fibroblasts. Normally, 
the wild-type ct subunit acquires high affinity ol bun- 
garotoxin binding in a time-dependent manner; how- 
ever, mutation of the 128 and/or 142 cysteines to ei- 
ther serine or alanine, as well as deletion of the entire 
14 amino acids in this region abolished all detectable 
high affinity binding. Nonglycosylated subunits that 
had a  serine to glycine mutation in the consensus se- 
quence also did not efficiently attain high affinity bind- 
ing to toxin. In contrast, mutation of the proline at 
position  136 to glycine or alanine, or a  double muta- 
tion of the cysteines at position  192  and 193 to serines 
had no effect on the acquisition of high affinity toxin 
binding.  These data suggest that a  disulfide bridge be- 
tween cysteines 128 and  142  and oligosaccharide addi- 
tion at asparagine 141  are required for the normal 
maturation of ot subunit as assayed by high affinity 
toxin binding. The unassembled wild-type ot subunit 
expressed in fibroblasts is normally degraded with a 
tlr2 of 2  h; upon assembly with the 6 subunit, the 
degradation rate slows significantly (tt/2 >  13 h). All 
mutated c~ subunits retained the capacity to assemble 
with a  6 subunit coexpressed in fibroblasts; however, 
mutated t~ subunits that were not glycosylated or did 
not acquire high affinity toxin binding were rapidly 
degraded (tlr2 =  20 rain to 2  h) regardless of whether 
or not they assembled with the ~ subunit.  Assembly 
and rapid degradation of nonglycosylated acetylcholine 
receptor (AChR) subunits and subunit complexes were 
also observed in tunicamycin-treated BC3H-1  cells, a 
mouse musclelike cell line that normally expresses 
functional AChR. Hence, rapid degradation may be 
one form of regulation assuring that only correctly 
processed and assembled subunits accumulate, and ul- 
timately make functional receptors in AChR-expressing 
cells. 
T 
hE muscle-type acetylcholine receptor (AChR),t orig- 
inally isolated from Torpedo electric organ, is the best 
characterized member of the family of ligand-gated ion 
channels and an ideal subject for studying the structural ele- 
ments required for normal assembly and expression of mul- 
timeric proteins. The AChR is composed of four different but 
homologous subunits with multiple transmembrane domains 
(Noda et al.,  1983) in a  stoichiometry of ot2/37~ (Karlin, 
1980).  The two ot subunits are not juxtaposed, having one 
subunit between them on one side and two on the other (Wise 
et al., 1981; Kistler et al., 1982; Zingsheim et al., 1982; Bon 
et al., 1984). The analysis of predicted protein sequences de- 
rived from cDNA clones for each of the subunits of muscle 
AChR from several species (Noda et al., 1983; Mishina et al., 
1986), and subunits cloned thus far for the neuronal nicotinic 
acetylcholine (Boulter et al.,  1986;  Goldman et al.,  1987), 
GABA^ (Schofield et al., 1987), and glycine (Grenningloh et 
al., 1987) receptors indicate at least two shared structural fea- 
tures that may lead to common posttranslational modifications 
1. Abbreviations  used in this paper:. AChR, acetylcholine receptor; Bq'x, c~ 
bungarotoxin. 
in this family of proteins.  First, 2 cysteines, 14 amino acids 
apart, that occur at positions  128  and  142  in the AChR a 
subunit, are thought to form a disulfide bridge. Second, a con- 
served N-linked glycosylation site, located at asparagine 141 
in the AChR et subunit, is just before the second of these cys- 
teines. 
Previous studies on the kinetics of maturation and assem- 
bly of the ot subunit expressed in a muscle cell line, BC3H-1, 
suggested that glycosylation  and a time-dependent posttrans- 
lational modification  that confers high affinity tx bungarotoxin 
(BTX) binding were required for the efficient assembly and 
subsequent expression of the AChR (Merlie et al.,  1982; 
Merlie and Lindstrom, 1983).  Here, we have generated by 
site-directed mutagenesis, and transfected into fibroblasts, 
several AChR o~ subunits that are not glycosylated and/or do 
not achieve a mature conformation. We present data consis- 
tent with the hypothesis that a disulfide bridge between cys- 
teines 128 and 142 is required for attainment of a mature 
conformation of a subunit as assayed by BTX binding. In ad- 
dition, by using the association of subunits in transfected 
fibroblasts as an assay for assembly, we show that mutated 
tx subunits retain the capacity to assemble with ~ subunit to 
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complex,  complexes made from mutated ~  subunits that 
were not glycosylated or did not acquire high affinity BTX 
binding were quickly degraded. Thus, rapid degradation of 
immature subunits and subunit complexes may be a mecha- 
nism by which incorrectly assembled receptor complexes are 
edited  to  preclude  surface  expression  of  nonfunctional 
AChR. 
Materials and Methods 
Cell Growth and Labeling 
Growth conditions for BC3H-I cells (Merlie and Sebbane, 1981; Merle and 
Lindstrom, 1983) and QT-6 cells (Moscovici et al., 1977; Blount and Mer- 
lie, 1988) as well as transfection, selection and maintenance of QT-6 clones 
expressing  ~  (Blount and Merlie,  1988),  c~ and %  and a  and c5 subunits 
(Blount and Merlie, 1989) of the mouse AChR have been described previ- 
ously; all subsequent clones have been derived and maintained similarly. 
Pulse labeling with [35S]methionine was performed at a final specific activ- 
ity of"~6 Ci/mmol for long pulses or 800 Ci/mmol for 5-rain pulses (Blount 
and Merlie, 1988). For cells that were chased, the media was removed sub- 
sequent to the pulse, and was replaced by conditioned media supplemented 
with l-mM unlabeled methionine. 
Construction  of a Subunit Mutations and 
Molecular Techniques 
All constructions are in M13 shuttle vectors (Blount and Merlie,  1988, 
1989). Single-strand preparations were made and point mutations were in- 
duced (Burke and Olson, 1986) using mutating oligonucleotides  with 10 bp 
flanking  the mutating base(s).  After transformation, M13 plaques were 
screened using differential  hybridization of the mutating oligonucleotide. 
The oligonucleotides  used to make the deletion mutants (128-142) and the 
142C~A mutant had 18-19 bp flanking the deleted bases; these mutants 
were screened with oligonucleotides  with 10 bp flanking the deletion. The 
normal sequence from 127 to 144 were changed to Tyr Asn Gly Ser Met 
and Tyr Ser Set Ser Met in the glycosylated and not glycosylated deletion 
mutants, respectively. The 192 +  193 CC~SS mutation was made with an 
oligonucleotide  with two mismatches.  All other double mutants weremade 
by sequential  mutations.  All mutations were confirmed by single stranded 
sequencing of the mutated area using an internal oligonucleotide primer and 
Sequenase  obtained from United States Biochemical (Cleveland,  OH). 
Replicative  form preparations purified through two cesium chloride gra- 
dients were made from these constructions for calcium phosphate transfec- 
tion. Transient transfections  were harvested 2 d after transfection; stable 
clones were selected and screened for subunit expression (Blount and Merlie, 
1988). The cell line expressing the ~ and ~5 subunits was stably transfected 
with the/~, 7, and ~ subunits; expression of the 7 subunit has not been de- 
tected by coimmunoprecipitation of subunits or immunofluorescence. 
Immunoprecipitations and Related Methods 
Labeled cells were washed twice with PBS, 300/~M PMSF at 4°C, scraped 
from the plates, and pelleted by centrifugation for 10 s in a microfuge. The 
cell pellet from a single 10-era dish was extracted with 1 ml PBS,  1-2% 
Triton X-100, 200 t~M leupeptin, and 0.2 U/nil ofc~2 macroglobulin for 3-5 
min, then the cells were centrifuged for 5 min in a microfuge and the super- 
natant collected.  Immunoprecipitations were performed as previously  de- 
scribed (Merlie and Sebbane,  1981; Merlie and Lindstrom,  1983) with 
modifications  (Blount and Merlie, 1988). The antibodies used were the c~ 
subunit-specific  monoclonal antibodies mAb61  (Tzartos et al.,  1981) and 
mAb210 (Rathman et al.,  1986),  a  rabbit polyclonal  anti-BTX  antibody 
used to precipitate cc subunit that was prebound to BTX (toxin antitoxin) 
(Merlie and Sebbane, 1981; Merlie and Lindstrom, 1983), the ~ subunit- 
specific mAb148 (Gullick and Lindstrom, 1983), and the 6 subunit-specific 
mAb88B (Froehner et al., 1983). After immunoprecipitation, Staphylococ- 
cus aureus pellets were resuspended in sample buffer and subjected to SDS- 
PAGE on a 10% acrylamide, 0.27 % N,N'-bis-methylene  acrylamide gel and 
buffer system previously described (Laemmli, 1970).  The gels were pro- 
cessed for fluorography;  band intensity was proportional to radioactivity 
and exposure time (Laskey and Mills, 1975). The percentages of association 
between subtmits were calculated by measuring  the fluorogram  intensities 
with a scanning densitometer (LKB Instruments, Inc., Gaithersburg, MD) 
and adjusting for immunoprecipitation effieiencies using t25I-BTX-labeled 
BC3H-1 AChR as an internal standard (Blount and Merlie,  1988). 
Binding Assay 
The binding of t25I-BTX to membranes prepared from fibroblast cells has 
been previously  described (Blount and Merlie,  1988) with modifications 
(Blount and Merlie, 1989). To determine if mutant ~6 complexes contained 
carbamyleholine binding sites, an inhibition of the initial rate of 12SI-BTX 
binding assay (Blount and Merlie,  1988, 1989) was used. 
Results 
Bungarotoxin Binding and Assembly of 
Subunit Mutants 
The ~ subunit of the AChR acquires high affinity BTX bind- 
ing in a time-dependent manner before (Merlie and Lind- 
strom, 1983) and independent of (Blount and Merlie,  1988) 
assembly with other subunits; however, the covalent modifi- 
cation(s) required for the maturation of the ot subunit is un- 
known. Merlie and Lindstrom (1983) speculated that the for- 
mation of a disulfide bridge may be the modification leading 
to a mature c~ subunit. Only four cysteines exist in the extra- 
cellular region of the AChR ot subunit. Two cysteines that 
make a rare  adjacent cysteine disulfide bridge (Kao et al., 
1984) are located at position 192 and 193 of the muscle ot 
subunit and are conserved in all ot subunits of the muscle- 
type and neuronal nicotinic receptors (Fig.  1 A). Two addi- 
tional cysteines are located at position  128 and 142 of the 
A 
r7 
~~M1/~--~-~M3  M4  e/-~tracellular 
..... 4=---=t1-~ ......  ~" ........  X .......................... t~t~;~i~  156-179 
e  Of  O~.. O  -~136,,0 
t 
......... T//'~C128 "',""  C142- S 1T)143'--"/~ ......... 
Figure  I.  Structure  of the muscle nicotinic AChR c~ subunit. A 
shows some structural features of the u  subunit. These include the 
four highly conserved membrane spanning domains labeled M1 to 
M4  and  a  putative loop  structure formed by a  disulfide bridge, 
depicted here as a  circle,  at amino acid positions 128-142.  Also 
shown are the two cysteines located at position 192 and 193 that 
are unique to the c~ subunit; these cysteines are conserved in some 
subunit clones isolated for neuronal AChRs.  An epitope between 
amino acid positions 156 and 179 has been mapped to the cytoplas- 
mic side of the protein by antibody binding to  Torpedo  vesicles 
(Criado et al.,  1985; Pedersen and Cohen, 1990a) and is depicted 
here as a  "V" dipping into the cytoplasmic domain.  The putative 
loop structure boxed in A is shown in greater detail in B. The pro- 
line approximately  half way  between the  two  cysteines  and  the 
glycosylation site just before the second cysteine are highly con- 
served among a  family of ligand-gated channels. 
The Journal of Cell Biology, Volume Ill,  1990  2614 Figure 2.  Immunoprecipitation of AChR subunits  from fibroblast  cells  expressing  mutated ¢x and wild-type/t subunits.  Mutations were 
made as described in experimental  procedures; stably transfected  fibroblasts eoexpressing  mutated c~ and wild-type 6 subunits of the AChR 
were labeled  with [35S]methionine for 1 h, harvested,  and extracted  as described in Materials  and Methods.  The mutated ¢x subunits were 
immunoprecipitated with the c~-specific monoclonal antibodies  mAb61  and rnAb210.  Toxin antitoxin  was used to immunoprecipitate c~ 
subunit that had acquired high affinity BTX binding (c~ax). The 6 subunit specific monoclonal antibody mAb88B was used to immunopre- 
cipitate 6 subunit,  and c~ subunit  associated with 6 subunit.  Precipitates  were analyzed by SDS-PAGE and the fluorograms are shown. 
Amino acid changes resulting  from the mutations are designated  by position, wild-type amino acid~mutant amino acid; each panel is 
labeled  at the bottom. The 6 subunit is marked by a bracket because of its heterogeneity in SDS-PAGE, and the ¢x subunit  is labeled  with 
a tick. As seen in 136P--'A, 6 subunit  is sometimes observed as a doublet. We suspect this to be a partially  glycosylated state of the 6 
subunit;  note the previously observed (Blount and Merlie,  1988) nonglycosylated tx subunit in the same panel. The ratio of a  precipitated 
by BTX to total ~x varied between experiments;  no consistent difference was observed in the efficiency of ¢xax formation between the wild- 
type cz subunit,  136P--'(G or A), or 192 +  193 CC~SS. Sequences for the deletion mutants A128-142, glycosylated and not glycosylated, 
are presented in Materials  and Methods. 136 shows an immunoprecipitation of a cell line expressing  only the/3, or expressing  the/3 and 
6 (/36) AChR subunits.  The lane BNS shows immunoprecipitation of a cell line expressing  only the 13 subunlt with the/3-specific  mAb148. 
The/36 cell line was immunoprecipitated with mAb148 and mAb88B; the lane NS is an immunopreeipitation where only the second antibody 
for mAb88B and S. aureus were added. The mutated c~, the wild-type 6, and the nonglycosylated mutated c~ subunits  (c~c) are labeled. 
Note that because the bands observed in the BNS lane are derived from a cell line that does not produce the 6 subunit,  the band eomigrating 
with 6 in the BNS and 148 lanes must be a nonspecific  protein.  This discrete nonspecifie  band has been previously observed (Blount and 
Merlie,  1989; Blount et al.,  1990),  and is also labeled  in the 192  +  193 CC'-"SS mutant. 
c~ subunit, and are conserved in all ligand-gated channel sub- 
units cloned thus far with the exception of  glutarnate receptor 
(Hollmann  et  al.,  1989).  These two cysteines  are thought 
to form a disulfide bridge with a proline approximately mid- 
way, and an N-linked glycosylation site one amino acid be- 
fore the  second cysteine (Fig.  1,  A  and B).  To determine 
if these  conserved  elements  are  required  for  the  normal 
maturation  of the AChR ot subunit,  a  series  of mutations 
were made in the ~x subunit by site directed mutagenesis. Ex- 
pression vectors encoding mutated proteins were transiently 
or stably transfected into QT-6 fibroblasts.  These cells were 
then  metabolically  labeled  for  1  h  with  [3~S]methionine, 
harvested,  immnnoprecipitated,  analyzed  by  SDS-PAGE, 
and visualized  by fluorography.  To assay  for high  affinity 
BTX binding, an antitoxin antibody was used to immunopre- 
cipitate BTX prebound to ot subunit (toxin antitoxin) (Merlie 
and Sebbane, 1982; Merlie and Lindstrom, 1983). As shown 
in Fig. 2, mutation of the proline at position 136 to alanine 
or mutation of the cysteines at positions 192 and 193 to ser- 
ines had no detectable effect on the expression of oL subunits 
acquiring high affinity BTX binding in this assay, suggesting 
that the posttranslational modification leading to the forma- 
tion of a high affinity BTX binding site is not dependent upon 
the 136 proline and cannot be the disulfide bridging of one 
or both of the cysteines located at  192 or 193.  In contrast, 
high affinity BTX binding was significantly reduced when 
the glycosylation consensus sequence was mutated (143S--" 
G), and no BTX binding was detected when cysteine at posi- 
tion 142 was changed to alanine. Deletion of the amino acids 
between position 128 and 142 in the ot subunit resulted in no 
detectable  high  affinity  BTX  binding  whether  or  not  the 
glycosylation site was preserved. 
From  results  of several  mutations  reviewed  in  Table  I, 
some generalizations  can be made.  First,  glycosylation is 
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on the Ability of the tr Subunit to Bind BTX 
and Associate with $ Subunit 
Mutation*  BTX binding~  t  a/~ association§ 
Wild type  +(6/6)  +(2/2) 
192  +  193 CC~SS  +(7/7)  +(2/2) 
Glycosylation 
143S-"G  - (7/8)  11  + (5/5) 
143S--,'G +  148T~N  -  + 
Loop mutations 
Cysteines 
128C~S  -(3/3)  + 
128C~A  -(5/5)  +(4/4) 
142C~S  -(3/3)  + 
142C~A  -(5/5)  +(1/1) 
128C~S  +  142C~S  -(6/6)  +(3/3) 
Proline 
136P~G  + (10/10)  + (6/6) 
136P~A  +(5/5)  +(3/3) 
Deletions 
A128-142 glycosylated  -(6/6)  +(5/5) 
A128-142 not glycosylated  -(3/3)  +(2/2) 
* Mutations were made as described  in Materials and Methods.  Amino acid 
changes resulting from these mutations are designated by position,  wild-type 
amino  acid~mutant amino  acid.  The  sequence  of the  deletion  mutants are 
presented  in Materials and Methods. 
¢ High affinity BTX binding was assayed by toxin antitoxin immunoprecipita- 
tion of extracts from cells pulse labeled with 13SS]methionine for 1 h. Precipi- 
tates  were  analyzed  by  SDS-PAGE  and  fluorography  as  in  Fig.  1  and 
densitomelric scanning. In some cases results were confirmed with a ~z~I-BTX 
binding assay previously described (Blount and Mealie, 1988). Positive results 
(+) ranged from '~15 to 40% of total t~ subunit with signals 3--40-fold above 
background determined by nonspecific immunopreeipitation.  Negative results 
were less than or equal to background.  All results were originally observed in 
transient transfections. Where applicable, the number of clones expressing the 
mutation showing the same properties/the  total number of clones expressing 
the mutation are shown in brackets. 
Association of oc and 6 subunits was assayed by coimmunoprecipitation  of 
the c~ subunit by the ~ subunit specific mAb88B from extracts of cells pulse la- 
beled with [35S]methionine for 1 h. Precipitates were analyzed by fluorogra- 
phy and densitometric scanning. Positive results (+) ranged from '~7 to 35% 
of total et subunit.  All results were originally observed  in transient transfec- 
tions of the mutant c~ subunits into a QT-6 clonal cell line transfected with and 
stably expressing the 5 subuult. Stably transfected cell lines expressing the mu- 
tant a  subunits and the wild-type 6 subunit were made by cotransfection of the 
two constructs and selection and screening of clones as described in Materials 
and Methods. Where applicable, the number of clones expressing the mutation 
showing the same properties/the  total number of clones expressing the muta- 
tion are shown in brackets. 
II In one high expressing  stably ttansfected  clone expressing this mutation,  a 
long fluorographic exposure suggested that <2 % of the ~ subunit was precipi- 
tated with toxin antitoxin as determined by densimetric  scanning. 
necessary for efficient acquisition of BTX binding; however, 
in  long  exposures  of fluorograms  from  high  expressing 
clones, ,,o2 % of  the nonglycosylated  t~ subunit made was de- 
tected using toxin antitoxin suggesting that glycosylation is 
not an absolute requirement. A mutation that reconstituted 
a glycosylation consensus sequence seven amino acids down 
stream  from  the  normal  glycosylation  site  (143S---G  + 
14STUN)  resulted  in  an  o~  subunit  with  electrophoretic 
migration identical to that of the glycosylated form, but did 
not restore the efficiency  of  acquisition of  BTX binding; thus, 
the requirement for glycosylation is site specific. Second, 
cysteines at positions 128 and 142, but not at 192 and 193, 
are required for acquisition of  high affinity BTX binding. De- 
letion of the amino acids between 128 and 142 (A 128-142, 
glycosylated or not glycosylated) confirmed that preserva- 
tion of secondary structure in this region is a requirement for 
normal expression of  high affinity BTX binding. Finally, mu- 
tation of  proline at position 136 had no effect, suggesting that 
this amino acid is not critical for acquisition of high affinity 
binding of toxin. All of these data are consistent with the hy- 
pothesis that a disulfide bridge between cysteines 128 and 
142 and glycosylation at asparagine 141 are required for the 
normal maturation of ct subunit of the AChR. 
Previously,  we  demonstrated  that  membranes  derived 
from stably transfected fibroblasts expressing the wild-type 
a  subunit had a K~ of 9.5  x  10  -H M for ~25I-BTX in a 22-h 
binding assay (Blount and Merlie,  1988). In art attempt to 
determine the extent of alteration of the binding properties 
of ot subunit mutants, we measured the apparent affinity of 
125I-BTX to membrane preparations from some of the fibro- 
blast cell lines expressing mutant c~ subunits. The 192 +  193 
CC--'SS mutant had a K,  pp for J25I-BTX binding of 9.2  x 
10  -~°  M,  an  affinity approximately  10-fold  less  than  the 
wild type. However, no specific binding was observed for the 
128C~S  +  142C-*S mutant in this assay at concentrations 
of 125I-BTX up to  1 x  10  -s M. Thus, mutations of the cys- 
teines at position 128 and 142 had dramatic effects (>1,000- 
fold) on affinity of  BTX for AChR ot subunit. In contrast, mu- 
tations of cysteines at position 192 and 193 reduced affinity 
of BTX by 10-fold. 
As an assay for assembly, shuttle vector constructions en- 
coding mutant oL subunits were transiently transfected into, 
and expressed in a fibroblast cell line stably expressing only 
wild-type ~ subunit;  alternatively, stably transfected fibro- 
blasts expressing both a  and 6 subunits were isolated. The 
coimmunoprecipitation of subunits  using  subunit  specific 
antibodies has been shown to be a sensitive and specific assay 
for assembly of these subunits (Blount and Merlie,  1990). 
However, the 6 subunit is often difficult to detect because it 
migrates  on  SDS-PAGE as  a  heterogeneous band,  comi- 
grates with a nonspecifically precipitated protein, and is ex- 
tremely sensitive to proteolysis. Therefore, the coimmuno- 
precipitation of ~ with 6 specific mAb88B (Froehner et al., 
1983), a more sensitive and reliable assay than coimmuno- 
precipitation of  6 with ct specific antibodies, was used to rou- 
tinely detect or/6 association.  One caveat to these experi- 
ments is that high levels of expression or nonstoichiometric 
expression of subunits in transfected fibroblasts may lead to 
nonspecific subunit association.  However, characterization 
of several clones expressing varying stoichiometries of  o~ and 
subunits as well as consistent observations made in tran- 
siently transfected fibroblasts decreases the likelihood of ar- 
tifactual subunit association. Although many of the mutated 
t~ subunits did not achieve a mature conformation as assayed 
by their ability to bind BTX with high affinity, they all assem- 
bled with 6 subunit in a coimmunoprecipitation assay (Fig. 
2 and Table I). Coimmunoprecipitation of subunits was also 
tested in a cell line stably coexpressing the/3 and 6 subunits 
(Fig. 2). Although the/3 subunit shares 40% identity with 
et subunit, and shares many of the same secondary structural 
features, 13 did not efficiently assemble with the ~ subunit. 
These data suggest that assembly of/3 with ~ subunit may be 
a late event in normal assembly of AChR subunits.  Hence, 
we conclude that structural domains present in ot that are re- 
quired for efficient assembly with 6 subunit are not present 
in the homologous/3 subunit. Furthermore, we suggest that 
although glycosylation and a disulfide bridge between cys- 
teines  128  and  142 are required for normal maturation of 
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S. aureus were added. Note the nonspecific band labeled with asterisks. The wild-type c~ and 5, and the 
and 3~6) subunits are labeled. 
Figure 3. Association of a and 
8 subunits expressed in tunica- 
mycin-treated fibroblasts. Con- 
fluent 60-min dishes of the tx/t 
cell line were incubated in the 
absence (Control)  or presence 
of 1.5/zg/ml  Tunicamycin for 
10 h.  The ceils were labeled 
with  [35S]methionine for 1 h, 
and then harvested and extract- 
ed as described  in Materials 
and  Methods.  The ot subunit 
was immunoprecipitated  with 
the tx-specific monoclonal an- 
tibodies mAbtl and mAb210. 
Toxin antitoxin  was  used  to 
immunoprecipitate  ~t subunit 
that had acquired high affinity 
BTX binding (otax). The ~ sub- 
unit-specific monoclonal anti- 
body  mAb88B  was  used  to 
immunoprecipitate/~  subunit, 
and ct subunit associated with 
the ~ subunit. Precipitates were 
only the second antibody and 
nonglycosylated tx and 8 (trNc 
a  subunit, they are not necessary for the assembly of tx and 
subunits. 
The ot~ and ot~¢ complexes form high affinity binding sites 
for small agonists and competitive antagonists that do not 
bind the unassembled a  subunit (Blount and Merlie,  1989). 
In addition, a recent affinity labeling study suggests that the 
binding site for these ligands may be at the interface of or3, 
and cx~ subunits (Pedersen and Cohen, 1990b). However, the 
structural requirements for the formation of this binding site 
are not known. Therefore, to determine if the 192 and 193 
cysteines or the proline at position 136 were requirements for 
the formation of an agonist binding site, we tested the ability 
of a high concentration (1 mM) of carbamylcholine, a small 
agonist, to inhibit Iz~I-BTX binding in membranes prepared 
from clones expressing mutant ot and wild-type ~ subunits. 
These studies demonstrated that in fibroblasts coexpressing 
the 192  +  193 CC--'SS or the 136P--'A mutant with fi sub- 
unit greater than 50% of the normal 12sI-BTX  binding could 
be inhibited by carbamylcholine, a  value similar to clones 
co-expressing the  wild-type tx and 3' or ct and  5  subunits 
(Blount and Merlie,  1989);  many of the  125I-BTX binding 
sites that were not inhibited by carbamylcholine are presum- 
ably unassembled a  subunits that bind tzq-BTX but not car- 
bamylcholine (Blount and Merlie,  1988,  1989).  Therefore, 
the cysteines at positions 192 and 193 and the proline at posi- 
tion 136 in the AChR et subunit are not critical for formation 
of a  carbamylcholine binding site. 
Assembly of Nonglycosylated a and ~ Subunits in 
Tunicamycin-treated Fibroblasts 
Experiments  using  the  N-linked  glycosylation  inhibitor, 
tunicamycin,  suggested that  glycosylation of subunits  was 
important  for normal  maturation and  assembly of mouse 
AChR subunits in BC3H-1 cells (Merlie et al.,  1982). How- 
ever, as seen in Fig.  2,  a  mutation that inhibits glycosyla- 
tion in the ot subunit did not prevent assembly of ot with 
subunit  in  stably  transfected  fibroblasts.  To  determine  if 
tunicamycin was preventing assembly of AChR subunits by 
a mechanism independent of inhibition of ot subunit glycosy- 
lation,  we  incubated  a  wild-type  or8  fibroblast  cell  line 
(Blount and Merlie,  1989,  1990) in the presence or absence 
of tunicamycin, pulse labeled the cells for 1 h with [3sS]me- 
thionine, and immunoprecipitated with subunit specific anti- 
bodies. As seen in the fluorogram presented in Fig. 3, tuni- 
camycin treatment of or8 cells increased the mobility of ot and 
subunits  on  SDS-PAGE and  substantially  decreased  the 
amount of tx subunit precipitated by toxin antitoxin, but did 
not prevent the assembly of tx subunit with 6. These data are 
•  .  ~.  . 
consistent with the charactermaUon of the ot subunit glycosy- 
lation mutation presented in Fig. 2, but are in apparent con- 
tradiction with the data obtained in BC3H-1 cells (Merlie et 
al.,  1982). 
Assembly and Degradation of Normal and 
Nonglycosylated AChR Subunits in Untreated and 
Tunicamycin-treated BC3H-1 Cells 
The half-life for degradation of unassembled AChR subunits 
in BC3H-1 cells has been determined to be only 15-30 min 
(Merlie and Lindstrom,  1983).  Therefore, it seemed possi- 
ble that nonglycosylated subunits expressed in tunicamycin- 
treated BC3H-1 cells did assemble, but that assembled prod- 
ucts were degraded as rapidly as unassembled subunits.  In 
an attempt to detect subunits that assembled but degraded rap- 
idly,  we repeated the  study of tunicamycin treated BC3H-1 
cells  using  very  short  [35S]methionine  pulse-labeling  and 
chase times. In this experiment, coimmunoprecipitation of 
ot with either B or 8 subunit specific antibodies (not available 
for the previous study) was used as an assay for assembly. 
BC3H-1  cells were pulse labeled with  [3~S]methionine  for 
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a  subunit by a B subunit-specific antibody. After a  5-min 
pulse only a small amount of ot is assembled with/3 subunit 
and the amount of assembly increases with increasing chase 
times. In contrast, in tunicamycin-treated BC3H-1 cells, no 
increase of assembled nonglycosylated o~ subunit was ob- 
served,  and  the  nonglycosylated /~  subunit  was  quickly 
degraded with a  tt/2 of ,x,43 min (Fig. 4  B).  However,  in 
long fluorographic exposures, a small amount of assembly 
was detected in tunicamycin-treated cells (Fig. 4  C). Non- 
glycosylated but assembled ct subunit was degraded with a 
tl/2 of •16  rain, essentially the same as the unassembled, 
nonglycosylated  ot subunit (Table II). Although we obtained 
similar results in this experiment using coimmunoprecipita- 
tion of ot with ~ subunit-specific antibody, the efficiency of 
the/3 subunit-specific antibody, mAb148 (Gullick and Lind- 
strom, 1983), and the resistance of the/3 subunlt to proteoly- 
sis made the coimmunoprecipitation of c~ with the/3 subunit 
Figure 4.  Kinetics of assembly and/or degradation of subunits in 
normal  and  tunicamycin-treated BC3H-1  cells.  Confluent  10-cm 
dishes of the BC3H-1  cell line were incubated in the absence (A) 
or presence of 1.5/~g/ml tunicamycin (B and C) for 10 h. The cells 
were labeled with [35S]methionine for 5  min and chased with con- 
ditioned media supplemented with I  mM methionine for the times 
(in minutes) indicated (Chase Time). The cells were then harvested 
and extracted as described in Materials and Methods. The/3 subunit 
was immunoprecipitated with the/3-specific monoclonal antibody 
mAb148.  The precipitates were analyzed by SDS-PAGE, and the 
fluorograms are shown. A  is a  6-d fluorographic exposure; B  and 
C  are from the identical gel, 5- and 27-d fluorographic exposures, 
respectively. The/~, the nonglycosylated/3 (~N6), and the coimmu- 
noprecipitating  a  and  nonglycosylated  et  subunit  (c~N~) are  la- 
beled. 
only 5  min; some cells  were then harvested while others 
were chased with conditioned media for increasing times be- 
fore harvesting. Fig. 4 A shows a fluorogram from untreated 
BC3H-1  cells showing the normal course of assembly over 
Table II. Half-Life for Degradation of Unassembled 
and Assembled Subunits 
Subunit  Half-life  for degradation 
In BC3H-1  Cells* 
Unassembled 
subunit  15-30 min 
Surface AChR  8  h 
Nonglycosylated 
unassembled 
c~ subunit  13 min 
Nonglycosylated 
t~ assembled with 
/3 subunit  16  min 
In transfected fibroblasts  Unassembled  Assembled with 
Wild-type ~ subunit  2  h  Not applicable 
Wild-type a  subunit  2  h  >  13  h 
192  +  193  CC-"SS 
a  subunit  ND  >  13  h 
136P-~G c~ subunit  ND  >  13  h 
143S~G  ct  subunit  17  rain  22  min 
128C~S+  142C~S 
subunit  1.2 h  1.0 h 
142C~A  ct subunit  2.0 h  1.8 h 
A128-142  glycosylated 
c~ subunit  1.5 h  1.7 h 
All half-lives for degradation  were calculated from densitometric  scans of ap- 
propriate fluorographic  exposures from pulse-chase labeling experiments. The 
half-life for degradation  of unassembled  wild-type c¢ subunit  in transfected 
fibroblasts was previously  published (Blount and Merlie, 1988) and has been 
confirmed in three independent clones. The half-life for degradation  of wild- 
type <5 subunlt was obtained from a cell line producing only the 6 subunit.  Mu- 
tations were made by site-directed  mutagenesis  as described in Materials  and 
Methods. Amino acid changes resulting  from these mutations  are designated 
by position, wild-type amino acid--,-mutant  amino acid. The half-life for degra- 
dation of unassembled, was calculated  from densitometric  scans of fluoro- 
grams of ~ subunit pulse-chase labeled and immunoprecipitated  with mAb61; 
ND, not determined. The half-life for degradation  of the unassembled 128C  ~ 
S +  142C-~S c~ subunit was not significantly different between a'clone produc- 
ing both the mutated c~ and ~ subunit and a clone producing only this mutated 
subunlt.  The half-lives for degradation  Of wild-type and mutated a  subunits 
assembled with 6 were calculated  from densitometric  scans of fluorographs 
with ~ coimmunoprecipitated  with the &specific antibody  mAb88B. 
* The half-lives  for degradation  of unassembled  c~ subunit  (Merlie  and Lind- 
strom, 1983) and surface AChR (Patrick  et al.,  1977) in BC3H-1 cells were 
previously  published.  The half-lives for degradation of the nonglycosylated  c~ 
subunlt in tunicamycin-treated  BC3H-I cells were calculated from densitomet- 
ric scans of appropriate  fluorographic  exposures from the experiment shown 
in Fig. 4. 
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tated and wild-type c~//i cell lines. Confluent 10-cm dishes of cell 
lines expressing mutated or wild-type cz and/i subunits were labeled 
with [35S]methionine for 5 min and chased with conditioned media 
supplemented  with  1  mM  methionine  for the  times  indicated 
(Chase llme in minutes, and TIME (HOURS) in C). The cells were 
then  harvested  and  extracted  as  described  in  Materials  and 
Methods.  The/i subunit was immunoprecipitated  with the/t-spe- 
cific monoclonal antibody mAb88B and the precipitates were ana- 
lyzed by SDS-PAGE. Fluorograms  are shown in A and B. A shows 
an experiment from a cell line coexpressing 143S--'G c~ and/i sub- 
unit, and B is from a cell line coexpressing  128C-'*S +  142C-'*S 
tx and/i subunit. The/i and the coimmunoprecipitating nonglycosyl- 
ated ct (OING)  and mutated tx subunit are labeled.  C shows quantita- 
five analysis, by densitometric scanning, of assembled ot in a cell line 
coexpressing wild-type ~x and/i subunits. The error bars in C are 
SEM of three independent experiments; data for each experiment 
were normalized to the maximum assembled c~ subunit. 
a more sensitive assay. In addition, data demonstrating that 
ot and/~ subunits associate only inefficiently in transfected 
fibroblasts (Blount and Merlie,  1989)  suggests that the as- 
sociation of these subunits may be a late event in assembly, 
and perhaps, a better assay for more complete and normal 
AChR assembly. Thus,  the nonglycosylated ot subunit  ex- 
pressed in tunicamycin-treated BC3H-1 cells has the poten- 
tial to assemble with other subunits, but the assembled prod- 
ucts are rapidly degraded. 
Kinetics of  Assembly and Degradation of 
Mutant and Wild-type ~  Subunit Complexes in 
Transfected Fibroblasts 
As demonstrated in Fig. 4, tunicamycin inhibition of N-linked 
glycosylation in the BC3H-1 cell line did not prevent assem- 
bly of nonglycosylated subunits; however, assembled prod- 
ucts were rapidly degraded. To determine ifa similar process 
occurs in transfected fibroblasts coexpressing a mutant, non- 
glycosylated, ot subunit with wild-type 5 subunit, we labeled 
these cells with [35S]methionine  for 5 min and immunopre- 
cipitated using a 5 subunit specific antibody. As seen in Fig. 
5 A, nonglycosylated a  subunit coimmunoprecipitated with 
subunit was degraded with a t~/2 of 22 min, a degradation 
rate similar to the unassembled nonglycosylated tx subunit 
(Table II). Similarly, the degradation rates of ol subunits with 
mutations at cysteines 128 and 142 or a deletion in this re- 
gion did not decrease upon association with ~ subunit (Fig. 
5 B and Table ID. In contrast, wild-type cz and 5 subunits as- 
sembled in fibroblasts in a time-dependent manner and, as 
previously described (Blount and Merlie,  1990), the result- 
ing complex had a half-life of 13 h,  6-10-fold greater than 
either the unassembled ct or 5 subunits (Fig. 5  C and Table 
II). Note that a small amount of assembly of wild-type ot with 
6 was observed at the earliest time point measured (Fig. 5 C, 
5-min pulse with no chase). This early assembly may be the 
same as that observed at the earliest time points in Fig.  5, 
A and B; however, in contrast to cells expressing wild-type 
a, accumulation of assembled complexes from these mutant 
ot subunits was not observed. 
Mutations that do not prevent acquisition of high affinity 
BTX  binding  could  have  subtle  effects  on  kinetics  of ot 
subunit  maturation  and  assembly.  However,  experiments 
similar to those presented  in  Fig.  5  demonstrated that  in 
fibroblast cell lines co-expressing wild-type ~ with either the 
136P--'G or the 192  +  193 CC~SS ot subunit, t~ subunit ac- 
quired high affinity BTX binding and assembled with 5 sub- 
unit with kinetics and efficiency indistinguishable from wild- 
type ot  subunit  (not  shown).  In addition,  the  ix6 complex 
formed in these cell lines had a degradation rate similar to 
the wild type (Table II). 
A summary of our data on degradation rates of assembled 
and unassembled subunits is presented in Table II. Collec- 
tively, these data suggest that glycosylated and cysteine 128 
and  142  disulfide bridged tx subunits  that have assembled 
into a heterologous tx~5  complex accumulate, while unassem- 
bled subunits and or6 complexes composed of tx subunits that 
are not glycosylated or have not made a  normal  128-142 
disulfide bridge are degraded. 
Discussion 
Expression of functional multimeric transmembrane recep- 
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subunit complex. However, the requirements for and regula- 
tion of subunit assembly are not well understood. Because 
of our current knowledge of the structure of muscle-type 
AChRs, we can use this molecule as a model for studying re- 
quirements for normal subunit association.  Here we have 
used the assembly of AChR o~ and ~ subunits in transfected 
fibroblasts (Blount et al., 1990) to analyze the effects of site- 
directed mutations of the a  subunit in an attempt to identify 
structural elements required for normal maturation and as- 
sembly of subunits. 
The interpretation of our results depends upon our using 
BTX binding as an assay for ct subunit maturation. Merlie 
and Lindstrom (1983) previously demonstrated that AChR tx 
subunit acquired high affinity B-I'X  binding in a time-dependent 
manner. Subsequently, we demonstrated that in stably trans- 
fected fibroblasts, ot subunit could acquire high affinity BTX 
binding in the absence of other subunits (Blount and Merlie, 
1988). These data suggested a covalent modification was re- 
quired for a  subunit maturation as assayed by BTX binding. 
The data presented here implicate ot subunit cysteines 128 
and 142 in this maturation. However, interpretation of  effects 
of mutation is not straightforward. The change of a single 
amino acid may cause loss of drug binding by interfering 
with folding (as we believe is the case for mutations of cys- 
teine 128 and 142), or, alternatively, mutations may directly 
influence the drug binding  site.  Several studies have sug- 
gested that an tx subunit domain to which BTX (W'dson et 
al., 1985; Neumann et al., 1986; Barakas et al., 1987; Wil- 
son and Lentz, 1988; Radding et al., 1988) and competitive 
antagonists (Kao et al.,  1984; Dennis, et al.,  1988) bind is 
located at or near the  192 and  193  cysteines. However, a 
study in which mutated Torpedo AChR a  subunits were co- 
expressed with wild-type/3, % and 6 in Xenopus oocytes sug- 
gested that cysteines 192 and 193 were not requirements for 
BTX binding (Mishina et al., 1985). The authors found that 
when cysteine at position 192 or 193 was mutated to serine, 
although no agonist gated ion channels were detected on the 
cell  surface,  a  significant  amount  of  carbamylcholine- 
inhibitable  BTX binding  sites  reached the  plasma  mem- 
brane. These data suggested that the 192 and 193 cysteines 
were not required for expression of agonist or BTX binding 
sites, but were required for channel gating. In contrast, when 
cysteine at positior~ 128 or 142 was mutated to serine, neither 
ligand-gated channels nor high affinity BTX binding sites 
were detected on the surface of the oocytes. Because only 
BTX binding sites that reached the oocyte plasma membrane 
were monitored, these results were inconclusive in deter- 
mining if  the cysteines at 128 and 142 were necessary for for- 
marion of oL subunit with high affinity BTX binding sites, or, 
alternatively, if these amino acids were required for the as- 
sembly of a  with other subunits or transport of assembled 
AChR to the cell surface. Consistent with the results of Mish- 
ina et al., 1985, we found that mutation of cysteines 192 and 
193  to  serines  did not interfere with  acquisition of high 
affinity BTX binding, assembly with 6 subunit, or formation 
of a carbamylcholine binding site. In addition, our data indi- 
cate that cysteines at position 128 and 142 are required for 
expression of any detectable high affinity BTX binding sites. 
The observation that mutation of  proline at position 136 does 
not inhibit ctr~ formation confirms that not all amino acids 
in this region are important for ot subunit maturation; how- 
ever, the deletion mutants suggest that the secondary struc- 
ture formed by these amino acids is critical for a mature con- 
formation. Analysis of double cysteine mutants (192  +  193 
CC-~SS and 128C-*S +  142 C~S) support the conclusion 
that our observations are due to lack of disulfide bridging, 
not formation of improper disulfide linkages or the presence 
of free sulfhydryls. Because mutation of either one or both 
of the cysteines at position 128 and 142 leads to absence of 
detectable BTX binding  in  our assay,  and  because these 
amino acids have not been implicated in agonist or BTX 
binding (as 192 and 193 cysteines have), our data strongly 
suggest that a disulfide bridge between cysteines at position 
128 and 142 is required for acquisition of high affinity BTX 
binding and a mature conformation of AChR,  subunit. 
The maturation of the o~ subunit is a slow event; maximum 
levels of otrx are not achieved until several minutes after o~ 
subunit synthesis.  Possible explanations for this delay in- 
clude (a) a slow isomerization of the proline at position 136, 
or,  (b) slow isomerization of disulfide bonds among the 4 
cysteines at positions 128, 142, 192, and 193 (Fig. 1 A) until 
the correct  disulfide configuration is achieved. Several previ- 
ous studies have suggested that either proline or disulfide 
bond isomerization can be rate limiting for normal protein 
folding (for review see Fischer and Schmid, 1990). If isom- 
erization of proline 136 or disulfide bond isomerization is 
rate limiting, mutation of proline 136 or a double mutation 
of cysteines at position 192 and 193 should significantly in- 
crease the rate of acquisition of high affinity BTX binding. 
Our  data,  however,  indicate  that  ot  subunit  mutated  at 
136P-*G, and the double mutant o~ 192  +  193 CC-*SS, ac- 
quire high affinity BTX binding with kinetics and efficiency 
indistinguishable from wild-type ~t subunit. Hence, neither 
isomerization of the proline at position 136 nor incorrect in- 
tramolecular disulfide bridging can account for the time- 
dependent nature of ot subunit maturation. 
Merlie et al. (1982) demonstrated that tunicamycin treat- 
ment of BC3H-1 cells decreased Otrx formation and AChR 
assembly, but not ct subunit synthesis. When it was discov- 
ered that ot subunit could acquire high affinity BTX binding 
subsequent to glycosylation but before assembly with other 
subunits (Merlie and Lindstrom, 1983), a sequential model 
for processing and assembly of AChR  subunits  was pro- 
posed. In this model, ct subunit is translated and cotransla- 
tionally glycosylated, acquires high affinity BTX binding in 
a  time-dependent  manner,  then  is  assembled  with  other 
subunits to form the AChR.  The time-dependent nature of 
formation of O~vx seemed sufficient to suggest this as rate 
limiting for assembly. However, because experimental inter- 
vention in the normal process of ot subunit maturation was 
not possible, the evidence that otr~ was required for subunit 
assembly  relied entirely on the  effect of tunicamycin on 
BC3H-1 cells and on kinetic studies. And indeed, this model 
was recently challenged when Xenopus oocytes injected with 
messenger RNA of Torpedo ix,/~, %  and ~ AChR subunits 
were  treated  with  tunicamycin,  and  assembly  of  non- 
glycosylated subunits was observed (Sumikawa and Miledi, 
1989). The results presented here for mouse AChR subunits 
expressed in fibroblasts confirm Sumikawa and Miledi's ob- 
servations. In addition, we demonstrate that although imma- 
ture t~  subunit can assemble,  the assembled products are 
short lived when compared to the correctly assembled prod- 
ucts. Because Xenopus oocytes have a relatively slow rate of 
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most likely a slow rate of degradation of all unassembled and 
assembled subuait species, it seems probable that even rela- 
tively rapidly degraded subunits are more easily observed in 
the oocyte expression system than the BC3H-1  or transfected 
fibroblast cell lines. Thus, our data present a resolution to 
an apparent paradox of the effects of tunicamycin on assem- 
bly of AChR subunits.  Moreover, our data suggest that cor- 
rectly processed and assembled subunit  complexes are rec- 
ognized by cellular transport or degradation machinery in a 
manner different from incorrectly processed and assembled 
complexes or unassembled subunits,  thereby  leading to the 
selective  accumulation  of  only  correct  assembly  inter- 
mediates. 
In conclusion, by studying individual and combinations of 
subunits expressed in fibroblasts,  we have gained insight into 
subunit maturation and regulation of assembly of the AChR. 
Mutational analysis suggests that acquisition of high affinity 
BTX binding requires the formation of a disulfide bridge be- 
tween cysteines 128 and 142 in ~x subunit. Because this pro- 
cessing step is time-dependent and relatively inefficient, it 
remains a possible site of regulation for AChR expression. 
The assembly  of CXTx with other  subunits  and  surface ex- 
pression of AChR appear to be specific and highly regulated. 
Previous work has  suggested that discrete assembly  inter- 
mediates  are  formed in  and confined to the  endoplasmic 
reticulum when o~ and 3' or c~ and fi subunits are coexpressed 
in fibroblasts (Blount et al., 1990). Mutational analysis now 
suggests  that  subunits  lacking N-linked  glycosylation or a 
disulfide bridge between cysteines  128 and 142 can assem- 
ble, but these incorrect assembly intermediates  are degraded, 
thus leading to accumulation, and ultimately,  expression of 
only correctly processed AChR. 
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